SONOSA for Detection of OSA
About 18 million people in the US and more than 100 million worldwide suffer from Obstructive Sleep Apnea (OSA), a dangerous condition associated with a range of severe comorbid conditions including heart disease, stroke, and diabetes. Tesserae has licensed the SONOSA device from the University of Maryland and is developing it as a product to help with the diagnosis and treatment of OSA. The SONOSA device uses ultrasound imaging to create an image of the patient's airway while they are sleeping (at home). The result provides unprecedented clarity for clinical intervention.
Tesserae has been funded by the Maryland Development Center.